Venetoclax and ibrutinib for patients with relapsed/refractory chronic lymphocytic leukemia.
Saved in:
| Title: | Venetoclax and ibrutinib for patients with relapsed/refractory chronic lymphocytic leukemia. |
|---|---|
| Authors: | Niemann CU; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Levin MD; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, The Netherlands., Dubois J; Department of Hematology, Amsterdam University Medical Center (UMC), University of Amsterdam, Amsterdam, The Netherlands., Kersting S; Department of Hematology, Haga Ziekenhuis, Den Haag, The Netherlands., Enggaard L; Department of Hematology, Herlev Hospital, Copenhagen, Denmark., Veldhuis GJ; Department of Hematology, Antonius Ziekenhuis, Sneek, The Netherlands., Mous R; Department of Hematology, Universitair Medisch Centrum Utrecht, Utrecht, The Netherlands., Mellink CHM; Department of Clinical Genetics and., Dobber JA; Laboratory of Hematology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Poulsen CB; Department of Hematology, Roskilde University Hospital, Roskilde, Denmark., Frederiksen H; Department of Hematology, Odense University Hospital, Odense, Denmark., Janssens A; Department of Hematology, Universitair Ziekenhuis Leuven, Leuven, Belgium., Schjødt I; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Dompeling EC; Department of Hematology, Isala Ziekenhuis, Zwolle, The Netherlands., Ranti J; Department of Hematology, Turku University Central Hospital, Turku, Finland., Mattsson M; Department of Hematology, Uppsala University Hospital, Uppsala, Sweden., Bellido M; Department of Hematology, UMC Groningen, University of Groningen, Groningen, The Netherlands., Tran HTT; Department of Hematology, Akershus University Hospital, Lørenskog, Norway; and., Nasserinejad K; HOVON Data Center, Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Kater AP; Department of Hematology, Amsterdam University Medical Center (UMC), University of Amsterdam, Amsterdam, The Netherlands. |
| Source: | Blood [Blood] 2021 Feb 25; Vol. 137 (8), pp. 1117-1120. |
| Publication Type: | Clinical Trial, Phase II; Letter; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
